Zhengzi Qian

机构：Tianjin Medical University Cancer Institute and Hospital

发表论文 28 篇 · 总被引 185 次 · h-index 7

代表论文

• Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCL (2022 · Journal for ImmunoTherapy of Cancer · 被引 65)
• A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphoma (2022 · Clinical Immunology · 被引 27)
• Pan-Cancer Analysis Reveals Genomic and Clinical Characteristics of TRPV Channel-Related Genes (2022 · Frontiers in Oncology · 被引 24)
• OX40 shapes an inflamed tumor immune microenvironment and predicts response to immunochemotherapy in diffuse large B-cell lymphoma (2023 · Clinical Immunology · 被引 13)
• A retrospective analysis of EBV‐DNA status with the prognosis of lymphoma (2022 · Journal of Cellular and Molecular Medicine · 被引 10)
• Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta-analysis (2022 · Annals of Hematology · 被引 8)